Extru-seq: a method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches
Authors
Jeonghun Kwon ; Minyoung Kim ; Woochang Hwang ; Anna Jo ; Gue-Ho Hwang ; Minhee Jung ; Un Gi Kim ; Gang Cui ; Heonseok Kim ; Joon-Ho Eom ; Junho K Hur ; Junwon Lee ; Youngho Kim ; Jin-Soo Kim ; Sangsu Bae ; Jungjoon K Lee
CRISPR ; Cell-based ; Genome-wide ; In vitro ; Off-target
Abstract
We present a novel genome-wide off-target prediction method named Extru-seq and compare it with cell-based (GUIDE-seq), in vitro (Digenome-seq), and in silico methods using promiscuous guide RNAs with large numbers of valid off-target sites. Extru-seq demonstrates a high validation rate and retention of information about the intracellular environment, both beneficial characteristics of cell-based methods. Extru-seq also shows a low miss rate and could easily be performed in clinically relevant cell types with little optimization, which are major positive features of the in vitro methods. In summary, Extru-seq shows beneficial features of cell-based and in vitro methods.